Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,950.00
+5.00 (0.10%)
At close: Mar 12, 2026
0.71% (1Y)
| Market Cap | 55.12B -13.0% |
| Revenue | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 11.14M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 185.00 (3.74%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 20,974 |
| Average Volume | 198,862 |
| Open | 4,945.00 |
| Previous Close | 4,945.00 |
| Day's Range | 4,885.00 - 5,000.00 |
| 52-Week Range | 4,355.00 - 7,690.00 |
| Beta | n/a |
| RSI | 40.49 |
| Earnings Date | Nov 27, 2025 |